Vancomycin minimum inhibitory concentration, host comorbidities and mortality in staphylococcus aureus bacteraemia
MetadataShow full item record
We reported an association between elevated vancomycin MIC and 30-day mortality in patients with Staphylococcus aureus bacteraemia (SAB), including patients with methicillin-susceptible S. aureus (MSSA) treated with flucloxacillin. A detailed analysis of comorbidities and disease severity scores in the same cohort of patients was performed to ascertain if unknown clinical parameters may have influenced these results. The association between elevated vancomycin MIC and 30-day mortality in SAB remained significant (p 0.001) on multivariable logistic regression analysis even when accounting for clinical factors. In addition, the association persisted when restricting analysis to patients with MSSA bacteraemia treated with flucloxacillin. This suggests that elevated vancomycin MIC is associated with but not causally linked to an organism factor that is responsible for increased mortality. © 2013 European Society of Clinical Microbiology and Infectious Diseases.
Showing items related by title, author, creator and subject.
Holmes, N.; Turnidge, J.; Munckhof, W.; Robinson, James; Korman, T.; O'Sullivan, M.; Anderson, T.; Roberts, S.; Warren, S.; Gao, W.; Howden, B.; Johnson, P. (2013)A ratio of the vancomycin area under the concentration-time curve to the MIC (AUC/MIC) of ≥ 400 has been associated with clinical success when treating Staphylococcus aureus pneumonia, and this target was recommended by ...
Effects of a statewide protocol for the management of peritoneal dialysis-related peritonitis on microbial profiles and antimicrobial susceptibilities: A retrospective five-year reviewMcGuire, A.; Carson, C.; Inglis, T.; Chakera, Aron (2015)Background: Peritonitis is a major complication of peritoneal dialysis (PD) and is associated with significant morbidity and mortality. Early empirical antibiotic therapy is recommended, with the choice of agents guided ...
Genetic and Molecular Predictors of High Vancomycin MIC in Staphylococcus aureus Bacteremia IsolatesHolmes, N.; Turnidge, J.; Munckhof, W.; Robinson, James; Korman, T.; O'Sullivan, M.; Anderson, T.; Roberts, S.; Warren, S.; Coombs, Geoffrey; Tan, H.; Gao, W.; Johnson, P.; Howden, B. (2014)An elevated vancomycin MIC is associated with poor outcomes in Staphylococcus aureus bacteremia (SAB) and is reported in patients with methicillin-susceptible S. aureus (MSSA) bacteremia in the absence of vancomycin ...